{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:04:29Z","timestamp":1789607069081,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2023-04080"],"award-info":[{"award-number":["RGPIN-2023-04080"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000033","name":"Institute of Musculoskeletal Health and Arthritis","doi-asserted-by":"publisher","award":["CIHR-168825"],"award-info":[{"award-number":["CIHR-168825"]}],"id":[{"id":"10.13039\/501100000033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajpath.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:46:04Z","timestamp":1778546764000},"page":"1708-1721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti\u2013Receptor Activator of Nuclear Factor-\u03baB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-\u03b12\u2013Deficient dy2J\/dy2J Dystrophic Mice"],"prefix":"10.1016","volume":"196","author":[{"given":"Zineb","family":"Bouredji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Facchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dounia","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9324-966X","authenticated-orcid":false,"given":"Norbert","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-5651","authenticated-orcid":false,"given":"Marthe","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Argaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4308-9418","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.04.011_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nmd.2021.04.003","article-title":"Merosin deficient congenital muscular dystrophy type 1A: an international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands","volume":"31","author":"Smeets","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2026.04.011_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/cam.22618","article-title":"Laminin-211 in skeletal muscle function","volume":"7","author":"Holmberg","year":"2013","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.ajpath.2026.04.011_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.ctm.2015.05.002","article-title":"Laminin-[alpha]2 chain-deficient congenital muscular dystrophy: pathophysiology and development of treatment","volume":"76","author":"Durbeej","year":"2015","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.ajpath.2026.04.011_bib4","first-page":"1","article-title":"Integrating activities of laminins that drive basement membrane assembly and function","volume":"76","author":"Yurchenco","year":"2015","journal-title":"Curr Top Membr"},{"key":"10.1016\/j.ajpath.2026.04.011_bib5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/humu.23599","article-title":"LAMA2 gene mutation update: toward a more comprehensive picture of the laminin-[alpha]2 variome and its related phenotypes","volume":"39","author":"Oliveira","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2026.04.011_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/s0960-8966(02)00266-3","article-title":"Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice","volume":"13","author":"Guo","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2026.04.011_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng1194-297","article-title":"Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene","volume":"8","author":"Xu","year":"1994","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.ajpath.2026.04.011_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnmol.2020.00059","article-title":"A family of laminin [alpha]2 chain-deficient mouse mutants: advancing the research on LAMA2-CMD","volume":"13","author":"Gawlik","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.ajpath.2026.04.011_bib9","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/hmg\/ddz180","article-title":"Pax7, Pax3 and Mamstr genes are involved in skeletal muscle impaired regeneration of dy2J\/dy2J mouse model of Lama2-CMD","volume":"28","author":"Yanay","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2026.04.011_bib10","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1093\/hmg\/ddr427","article-title":"Autophagy is increased in laminin [alpha]2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A","volume":"20","author":"Carmignac","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2026.04.011_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0197388","article-title":"Natural disease history of the dy2J mouse model of laminin [alpha]2 (merosin)-deficient congenital muscular dystrophy","volume":"13","author":"Pasteuning-Vuhman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2026.04.011_bib12","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/ddz124","article-title":"An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice","volume":"28","author":"Hamoudi","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2026.04.011_bib13","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cells12111538","article-title":"RANKL inhibition reduces cardiac hypertrophy in mdx mice and possibly in children with Duchenne muscular dystrophy","volume":"12","author":"Marcadet","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2026.04.011_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","article-title":"Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy","volume":"6","author":"Dufresne","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ajpath.2026.04.011_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","article-title":"NF-[kappa]B-mediated regulation of osteoclastogenesis","volume":"30","author":"Boyce","year":"2015","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2026.04.011_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddz312","article-title":"Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice","volume":"29","author":"Hamoudi","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2026.04.011_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse","volume":"14","author":"Briguet","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2026.04.011_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0014-4886(83)90297-2","article-title":"Changes in isometric contractile properties of fast-twitch and slow-twitch skeletal muscle of C57BL 6J dy2J dy2J dystrophic mice during postnatal development","volume":"80","author":"Bressler","year":"1983","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ajpath.2026.04.011_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0146471","article-title":"Bortezomib does not reduce muscular dystrophy in the dy2j\/dy2j mouse model of laminin [alpha]2 chain-deficient muscular dystrophy","volume":"11","author":"K\u00f6rner","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2026.04.011_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9030244","article-title":"Antioxidants reduce muscular dystrophy in the dy2J\/dy2J mouse model of laminin [alpha]2 chain-deficient muscular dystrophy","volume":"9","author":"Harandi","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ajpath.2026.04.011_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bone.2010.09.011","article-title":"Mechanical, biochemical and morphometric alterations in the femur of mdx mice","volume":"48","author":"Nakagaki","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2026.04.011_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11914-018-0468-2","article-title":"Targeting the muscle-bone unit: filling two needs with one deed in the treatment of Duchenne muscular dystrophy","volume":"16","author":"Boulanger Piette","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ajpath.2026.04.011_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biomedicines5040062","article-title":"Muscle\u2013bone crosstalk: emerging opportunities for novel therapeutic approaches to treat musculoskeletal pathologies","volume":"5","author":"Maurel","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2026.04.011_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000046435","article-title":"The impact of muscular dystrophy on limb bone growth and scaling in mice","volume":"162","author":"Lammers","year":"1998","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.ajpath.2026.04.011_bib25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.410","article-title":"Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans","volume":"26","author":"Rufo","year":"2011","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.ajpath.2026.04.011_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00223-023-01116-w","article-title":"Anti-RANKL therapy prevents glucocorticoid-induced bone loss and promotes muscle function in a mouse model of Duchenne muscular dystrophy","volume":"113","author":"Jayash","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ajpath.2026.04.011_bib27","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"JCI"},{"key":"10.1016\/j.ajpath.2026.04.011_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.ejhg.5200743","article-title":"Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin)","volume":"10","author":"Allamand","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajpath.2026.04.011_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158397","article-title":"Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-[alpha]LN linker protein","volume":"7","author":"McKee","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2026.04.011_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fendo.2019.00236","article-title":"Updates on osteoimmunology: what's new on the cross-talk between bone and immune system","volume":"10","author":"Ponzetti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajpath.2026.04.011_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2016.03.013","article-title":"Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury","volume":"94","author":"Carbone","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpath.2026.04.011_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-510X(86)90004-3","article-title":"Protein profiles of sarcoplasmic reticulum from normal and dystrophic mouse muscle","volume":"72","author":"Butcher","year":"1986","journal-title":"J Neurol Sci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:25:17Z","timestamp":1789604717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0002944026001331"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.04.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013Receptor Activator of Nuclear Factor-\u03baB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-\u03b12\u2013Deficient dy2J\/dy2J Dystrophic Mice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}